These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 11219471

  • 1. Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study.
    Freytag F, Schelling A, Meinicke T, Deichsel G, Telmisartan Hypertension Experience in a Randomized European Study Versus Atenolol Study Group.
    Clin Ther; 2001 Jan; 23(1):108-23. PubMed ID: 11219471
    [Abstract] [Full Text] [Related]

  • 2. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB, Reilly PA.
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [Abstract] [Full Text] [Related]

  • 3. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y, Neutel JM, Schumacher H.
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [Abstract] [Full Text] [Related]

  • 4. Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension.
    Neutel JM, Frishman WH, Oparil S, Papademitriou V, Guthrie G.
    Am J Ther; 1999 May; 6(3):161-6. PubMed ID: 10423659
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
    Manolis AJ, Reid JL, de Zeeuw D, Murphy MB, Seewaldt-Becker E, Köster J, ARAMIS Study Group.
    J Hypertens; 2004 May; 22(5):1033-7. PubMed ID: 15097245
    [Abstract] [Full Text] [Related]

  • 6. Comparison of a fixed-dose combination of 40 mg telmisartan plus 12.5 mg hydrochlorothiazide with 40 mg telmisartan in the control of mild to moderate hypertension.
    Lacourcière Y, Martin K.
    Am J Ther; 2002 May; 9(2):111-7. PubMed ID: 11897925
    [Abstract] [Full Text] [Related]

  • 7. Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension.
    McGill JB, Reilly PA.
    Clin Cardiol; 2001 Jan; 24(1):66-72. PubMed ID: 11195609
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
    Karlberg BE, Lins LE, Hermansson K.
    J Hypertens; 1999 Feb; 17(2):293-302. PubMed ID: 10067800
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.
    Zhu DL, Bays H, Gao P, Mattheus M, Voelker B, Ruilope LM.
    Clin Ther; 2012 Jul; 34(7):1613-24. PubMed ID: 22717420
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study.
    Sung KC, Oh YS, Cha DH, Hong SJ, Won KH, Yoo KD, Rha SW, Ahn YK, Ahn JC, Jang JY, Hong TJ, Cho SK, Park SH, Hyon MS, Nam CW, Chae IH, Yoo BS, Song JM, Jeong JO, Yoon YW, Kim BS, Yang TH, Cho DK, Kim SH, Choi YJ, Ahn JH, Jeon DW, Kim HS.
    Clin Ther; 2018 Jan; 40(1):50-63.e3. PubMed ID: 29248384
    [Abstract] [Full Text] [Related]

  • 12. Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications.
    Neutel JM, Klein C, Meinicke TW, Schumacher H.
    Blood Press; 2002 Jan; 11(5):302-9. PubMed ID: 12458653
    [Abstract] [Full Text] [Related]

  • 13. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM, Kolloch RE, Plouin PF, Meinicke TW, Schumacher H, OTELLOH Study Group.
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy.
    Lacourcière Y, Tytus R, O'Keefe D, Lenis J, Orchard R, Martin K.
    J Hum Hypertens; 2001 Nov; 15(11):763-70. PubMed ID: 11687919
    [Abstract] [Full Text] [Related]

  • 15. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y, Neutel JM, Davidai G, Koval S.
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication.
    Neldam S, Edwards C.
    Expert Opin Pharmacother; 2009 Feb; 10(3):345-52. PubMed ID: 19191674
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
    Os I, Hotnes T, Dollerup J, Mogensen CE.
    Am J Hypertens; 1997 Aug; 10(8):899-904. PubMed ID: 9270085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.